| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.035 | 0.8 |